Ever since the introduction of Medicare Advantage plans and their predecessors, certain idealogues have tried to undermine and discredit the program. And while MA may cost more for a beneficiary than the fee-for-service program would spend, the beneficiary typically gets better benefits and according to most research, better quality and coordination of care. (HA Article) In a new study the authors looked at care between 2003 and 2009 for matched beneficiaries in Medicare Advantage and in the fee-for-service program. The primary measures were HEDIS data and CAHPS surveys of satisfaction. Even without accounting for spillover effects from Medicare Advantage to the fee-for-service population, MA plans shows a pretty wide gap in performance on several measures. Mammography rates were 13.5% higher; HbA1c testing for diabetic patients was 8.6% higher, eye exams for patients with diabetes were 17.1% greater, and cholesterol testing was 7% to 9% higher. Rates of flu and pneumonia vaccinations were similar. Ratings of physicians in the satisfaction surveys were basically the same, with a slight edge for MA for primary care physicians. Non-profit, larger and longer operating health plans showed the greatest gap in quality performance versus the fee-for-service program. The study used mostly process of care measures, not actual health outcomes, but it strongly suggests that fears that MA plans would be incented to skimp on care are unfounded and that it is the uncoordinated, unmanaged fee-for-service program that is delivering more sub-optimal care.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace